AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
BCL-2 BUT NOT P53 EXPRESSION IS ASSOCIATED WITH RESISTANCE TO CHEMOTHERAPY IN ADVANCED BREAST-CANCER
Authors: BONETTI A ZANINELLI M LEONE R CETTO GL PELOSI G BIOLO S MENGHI A MANFRIN E BONETTI F PIUBELLO Q
Citation: A. Bonetti et al., BCL-2 BUT NOT P53 EXPRESSION IS ASSOCIATED WITH RESISTANCE TO CHEMOTHERAPY IN ADVANCED BREAST-CANCER, Clinical cancer research, 4(10), 1998, pp. 2331-2336
TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: DELFAVERO A ROILA F DEANGELIS V TONATO M BALLATORI E TUMOLO S MENEGHETTI L NEGRI D DELLAGASPERA S PRESOT C MURAN G LUCENTI A CICCARESE G PALLADINO MA PORROZZI S SABBATINI R DEPENNI R FEDERICO M SILINGARDI V SANSONI E MALTONI M MILANDRI C AMADORI D SABBIONI R NORTILLI R CETTO GL DOGLIOTTI L BUNIVA T GORZEGNO G LOPEZ M AMODIO A CONTI F FOGGI CM GIGLIO A DESIO L MANENTE P BERNARDO G STRADA MR VILLANI G GALLO L MERLINI L CAROTI C MAZZOTTA S FORCIGNANO R QUARTA G PACILIO C IODICE G ROSATI G MALACARNE P DONATI D MACCAFERRI R COMELLA G CASARETTI R CARRECA I RAUSA L FOSSER V SCHIAVON S GIOFFRE FM VENUTI A AMUNNI G VILLANUCCI A CONTU A PAZZOLA A PALMIOTTI G GAROFOLO G EPIFANI C GIORDANO M ANTIMI M MINELLI M DEVITA F DIGRAZIA M CRUCIANI G MONTANARI L MARCHEI P AMICI S ALESSANDRONI P CECCOLINI M CATTANEO MT ORLANDINI B AGOSTARA B MARZI M DIONISI MS DICOSTANZO F TROCCOLI L
Citation: A. Delfavero et al., TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Annals of oncology, 9(7), 1998, pp. 759-765
DOES BONE-MARROW INVOLVEMENT AFFECT PROGNOSIS IN SMALL-CELL LUNG-CANCER
Authors: PASINI F CETTO GL PELOSI G
Citation: F. Pasini et al., DOES BONE-MARROW INVOLVEMENT AFFECT PROGNOSIS IN SMALL-CELL LUNG-CANCER, Annals of oncology, 9(3), 1998, pp. 247-250
POSITIVE IMMUNOSTAINING WITH MLUC1 OF BONE-MARROW ASPIRATE PREDICTS POOR OUTCOME IN PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: PASINI F PELOSI G VERLATO G GUIDI G PAVANEL F TUMMARELLO D MASOTTI A CETTO GL
Citation: F. Pasini et al., POSITIVE IMMUNOSTAINING WITH MLUC1 OF BONE-MARROW ASPIRATE PREDICTS POOR OUTCOME IN PATIENTS WITH SMALL-CELL LUNG-CANCER, Annals of oncology, 9(2), 1998, pp. 181-185
IMMUNODETECTION OF BREAST-CANCER CELLS IN BONE-MARROW FOR MONITORING HIGH-DOSE SEQUENTIAL CHEMOTHERAPY
Authors: PELOSI G MOLINO A PAVANEL F TURAZZA M CETTO GL
Citation: G. Pelosi et al., IMMUNODETECTION OF BREAST-CANCER CELLS IN BONE-MARROW FOR MONITORING HIGH-DOSE SEQUENTIAL CHEMOTHERAPY, Applied immunohistochemistry, 5(1), 1997, pp. 67-70
COMBINATION OF CHEMOTHERAPY AND RADIOTHERAPY IMPROVES THE CURE RATE IN PRIMARY EXTRANODAL LYMPHOMAS OF THE HEAD AND NECK (PLHN)
Authors: PASINI F CETTO GL TODESCHINI G DIMARCO A VERLATO G SCOGNAMIGLIO F MENEGHINI V CORATO A AMBROSETTI A
Citation: F. Pasini et al., COMBINATION OF CHEMOTHERAPY AND RADIOTHERAPY IMPROVES THE CURE RATE IN PRIMARY EXTRANODAL LYMPHOMAS OF THE HEAD AND NECK (PLHN), Anticancer research, 17(4A), 1997, pp. 2837-2842
PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS - A COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL METHODS
Authors: MOLINO A MICCIOLO R TURAZZA M BONETTI F PIUBELLO Q CORGNATI A SPEROTTO L RECALDIN E SPAGNOLLI P MANFRIN E BONETTI A NORTILLI R TOMEZZOLI A POLLINI GP MODENA S CETTO GL
Citation: A. Molino et al., PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS - A COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL METHODS, Breast cancer research and treatment, 45(3), 1997, pp. 241-249
BONE-MARROW MICROMETASTASES IN 109 BREAST-CANCER PATIENTS - CORRELATIONS WITH CLINICAL AND PATHOLOGICAL FEATURES AND PROGNOSIS
Authors: MOLINO A PELOSI G TURAZZA M SPEROTTO L BONETTI A NORTILLI R FATTOVICH G ALAIMO C PIUBELLO Q PAVANEL F MICCIOLO R CETTO GL
Citation: A. Molino et al., BONE-MARROW MICROMETASTASES IN 109 BREAST-CANCER PATIENTS - CORRELATIONS WITH CLINICAL AND PATHOLOGICAL FEATURES AND PROGNOSIS, Breast cancer research and treatment, 42(1), 1997, pp. 23-30
KI-67 IMMUNOSTAINING IN 322 PRIMARY BREAST-CANCERS - ASSOCIATIONS WITH CLINICAL AND PATHOLOGICAL VARIABLES AND PROGNOSIS
Authors: MOLINO A MICCIOLO R TURAZZA M BONETTI F PIUBELLO Q BONETTI A NORTILLI R PELOSI G CETTO GL
Citation: A. Molino et al., KI-67 IMMUNOSTAINING IN 322 PRIMARY BREAST-CANCERS - ASSOCIATIONS WITH CLINICAL AND PATHOLOGICAL VARIABLES AND PROGNOSIS, International journal of cancer, 74(4), 1997, pp. 433-437
INDUCTIVELY-COUPLED PLASMA-MASS SPECTROSCOPY QUANTITATION OF PLATINUM-DNA ADDUCTS IN PERIPHERAL-BLOOD LEUKOCYTES OF PATIENTS RECEIVING CISPLATIN-BASED OR CARBOPLATIN-BASED CHEMOTHERAPY
Authors: BONETTI A APOSTOLI P ZANINELLI M PAVANEL F COLOMBATTI M CETTO GL FRANCESCHI T SPEROTTO L LEONE R
Citation: A. Bonetti et al., INDUCTIVELY-COUPLED PLASMA-MASS SPECTROSCOPY QUANTITATION OF PLATINUM-DNA ADDUCTS IN PERIPHERAL-BLOOD LEUKOCYTES OF PATIENTS RECEIVING CISPLATIN-BASED OR CARBOPLATIN-BASED CHEMOTHERAPY, Clinical cancer research, 2(11), 1996, pp. 1829-1835
PRIMARY EXTRANODAL LYMPHOMAS OF WALDEYERS RING, STAGE IE AND IIE - LONG-TERM SURVIVAL AFTER CHEMOTHERAPY COMBINED WITH RADIOTHERAPY
Authors: PASINI F BASSETTO MA TODESCHINI G DIMARCO A VERLATO G SCOGNAMIGLIO F ZANOTTI R VENERI D CETTO GL AMBROSETTI A
Citation: F. Pasini et al., PRIMARY EXTRANODAL LYMPHOMAS OF WALDEYERS RING, STAGE IE AND IIE - LONG-TERM SURVIVAL AFTER CHEMOTHERAPY COMBINED WITH RADIOTHERAPY, International journal of oncology, 9(4), 1996, pp. 777-780
TUMOR PROLIFERATIVE ACTIVITY AND RESPONSE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CARCINOMA
Authors: BONETTI A ZANINELLI M RODELLA S MOLINO A SPEROTTO L PIUBELLO Q BONETTI F NORTILLI R TURAZZA M CETTO GL
Citation: A. Bonetti et al., TUMOR PROLIFERATIVE ACTIVITY AND RESPONSE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CARCINOMA, Breast cancer research and treatment, 38(3), 1996, pp. 289-297
HIGH-DOSE SEQUENTIAL CHEMOTHERAPY (ICE) UNDER CIRCULATING PROGENITOR CELLS (CPC) PROTECTION IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC) - PRELIMINARY-REPORT ON A MULTICENTRIC STUDY
Authors: LEYVRAZ S LANGE A PEREY L KETTERER N BOSQUEE L ROSTI G PASINI F HAMDAN O HUMBLET Y CETTO GL MARANGOLO M
Citation: S. Leyvraz et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY (ICE) UNDER CIRCULATING PROGENITOR CELLS (CPC) PROTECTION IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC) - PRELIMINARY-REPORT ON A MULTICENTRIC STUDY, European journal of cancer, 31A, 1995, pp. 90-90
PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS (BC) - A COMPARISON OF IMMUNOHISTOCHEMICAL (ICA) AND BIOCHEMICAL (DCC) METHODS
Authors: MOLINO A TURAZZA M BONETTI F PIUBELLO Q CORGNATI A SPEROTTO L RECALDIN E SPAGNOLLI P MANFRIN E BONETTI A NORTILLI R TOMEZZOLI A POLLINI GP MODENA S CETTO GL MICCIOLO R
Citation: A. Molino et al., PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTORS IN 405 PRIMARY BREAST CANCERS (BC) - A COMPARISON OF IMMUNOHISTOCHEMICAL (ICA) AND BIOCHEMICAL (DCC) METHODS, European journal of cancer, 31A, 1995, pp. 690-690
PLATINUM-DNA ADDUCTS IN PERIPHERAL-BLOOD LEUKOCYTES OF PATIENTS RECEIVING CISPLATIN-BASED OR CARBOPLATIN-BASED CHEMOTHERAPY - CORRELATION WITH CISPLATIN IN-VITRO TREATMENT AND WITH CLINICAL ACTIVITY
Authors: BONETTI A APOSTOLI P ZANINELLI M CETTO GL PAVANEL F FRANCESCHI T COLOMBATTI M LEONE R
Citation: A. Bonetti et al., PLATINUM-DNA ADDUCTS IN PERIPHERAL-BLOOD LEUKOCYTES OF PATIENTS RECEIVING CISPLATIN-BASED OR CARBOPLATIN-BASED CHEMOTHERAPY - CORRELATION WITH CISPLATIN IN-VITRO TREATMENT AND WITH CLINICAL ACTIVITY, European journal of cancer, 31A, 1995, pp. 965-965
SOLUBLE CD30 (SCD30) SERUM LEVELS IN PATIENTS WITH EMBRIONAL CARCINOMA (EC) OR MIXED GERM-CELL TUMORS (GCT) WITH EMBRIONAL COMPONENT
Authors: PASINI F BASSETTO MA SABBIONI R CETTO GL SCOGNAMMIGLIO F PIZZOLO G
Citation: F. Pasini et al., SOLUBLE CD30 (SCD30) SERUM LEVELS IN PATIENTS WITH EMBRIONAL CARCINOMA (EC) OR MIXED GERM-CELL TUMORS (GCT) WITH EMBRIONAL COMPONENT, European journal of cancer, 31A, 1995, pp. 1187-1187
DETECTION AT DIAGNOSIS OF TUMOR-CELLS IN BONE-MARROW ASPIRATES OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND CLINICAL CORRELATIONS
Authors: PASINI F PELOSI G MOSTACCI R SANTO A MASOTTI A SPAGNOLLI P RECALDIN E CETTO GL
Citation: F. Pasini et al., DETECTION AT DIAGNOSIS OF TUMOR-CELLS IN BONE-MARROW ASPIRATES OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND CLINICAL CORRELATIONS, Annals of oncology, 6(1), 1995, pp. 86-88
EXTRAGONADAL GERM-CELL TUMOR - A CLINICAL-STUDY
Authors: BASSETTO MA PASINI F FRANCESCHI T MUSTACCHI G CETTO GL
Citation: Ma. Bassetto et al., EXTRAGONADAL GERM-CELL TUMOR - A CLINICAL-STUDY, Anticancer research, 15(6B), 1995, pp. 2751-2754
ESTROGEN-RECEPTORS IN 699 PRIMARY BREAST CANCERS - A COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL METHODS
Authors: MOLINO A MICCIOLO R TURAZZA M BONETTI F PIUBELLO Q CORGNATI A SPEROTTO L MARTIGNONI G BONETTI A NORTILLI R CASTELLI P RODELLA S CAPELLI P MANFRIN E PELOSI G CETTO GL
Citation: A. Molino et al., ESTROGEN-RECEPTORS IN 699 PRIMARY BREAST CANCERS - A COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL METHODS, Breast cancer research and treatment, 34(3), 1995, pp. 221-228
CISPLATIN PHARMACOKINETICS USING A 5-DAY SCHEDULE DURING REPEATED COURSES OF CHEMOTHERAPY IN GERM-CELL TUMORS
Authors: BONETTI A FRANCESCHI T APOSTOLI P MESSORI A SPEROTTO L CETTO GL MOLINO A LEONE R
Citation: A. Bonetti et al., CISPLATIN PHARMACOKINETICS USING A 5-DAY SCHEDULE DURING REPEATED COURSES OF CHEMOTHERAPY IN GERM-CELL TUMORS, Therapeutic drug monitoring, 17(1), 1995, pp. 25-32
POSTOPERATIVE CHEMOTHERAPY INCREASES THE DISEASE-FREE SURVIVAL RATE IN PRIMARY GASTRIC LYMPHOMAS STAGE IE AND IIE
Authors: PASINI F AMBROSETTI A SABBIONI R TODESCHINI G SANTO A MENEGHINI V PERONA G CETTO GL
Citation: F. Pasini et al., POSTOPERATIVE CHEMOTHERAPY INCREASES THE DISEASE-FREE SURVIVAL RATE IN PRIMARY GASTRIC LYMPHOMAS STAGE IE AND IIE, European journal of cancer, 30A(1), 1994, pp. 33-36
CISPLATIN PHARMACOKINETICS IN ELDERLY PATIENTS
Authors: BONETTI A FRANCESCHI T APOSTOLI P CETTO GL RECALDIN E MOLINO A LEONE R
Citation: A. Bonetti et al., CISPLATIN PHARMACOKINETICS IN ELDERLY PATIENTS, Therapeutic drug monitoring, 16(5), 1994, pp. 477-482
DETECTION OF SMALL-CELL-LUNG-CANCER CELLS IN BONE-MARROW ASPIRATES BYMONOCLONAL-ANTIBODIES NCC-LU-243, NCC-LU-246 AND MLUC1
Authors: PASINI F PELOSI G LEDERMANN JA CETTO GL
Citation: F. Pasini et al., DETECTION OF SMALL-CELL-LUNG-CANCER CELLS IN BONE-MARROW ASPIRATES BYMONOCLONAL-ANTIBODIES NCC-LU-243, NCC-LU-246 AND MLUC1, International journal of cancer, 1994, pp. 53-56
INDEPENDENT EXPRESSION OF P55 AND P75 INTERLEUKIN-2 RECEPTORS (IL-2R)DURING INTRAVENOUS OR SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY T-LYMPHOCYTES AND NATURAL-KILLER-CELLS
Authors: ZAMBELLO R TRENTIN L CERUTTI A ENTHAMMER C MILANI A FRANCESCHI T MESSINA C CETTO GL AGOSTINI C SEMENZATO G
Citation: R. Zambello et al., INDEPENDENT EXPRESSION OF P55 AND P75 INTERLEUKIN-2 RECEPTORS (IL-2R)DURING INTRAVENOUS OR SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY T-LYMPHOCYTES AND NATURAL-KILLER-CELLS, Cancer, 74(9), 1994, pp. 2562-2569
INDEPENDENT EXPRESSION OF P55 AND P75 INTERLEUKIN-2 RECEPTORS (IL-2R)DURING INTRAVENOUS OR SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY T-LYMPHOCYTES AND NATURAL-KILLER-CELLS
Authors: ZAMBELLO R TRENTIN L CERUTTI A ENTHAMMER C MILANI A FRANCESCHI T MESSINA C CETTO GL AGOSTINI C SEMENZATO G
Citation: R. Zambello et al., INDEPENDENT EXPRESSION OF P55 AND P75 INTERLEUKIN-2 RECEPTORS (IL-2R)DURING INTRAVENOUS OR SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY T-LYMPHOCYTES AND NATURAL-KILLER-CELLS, Cancer, 74(9), 1994, pp. 2562-2569
Risultati: 1-25 | 26-26